IR Roundtable Applications Close Today
|
Hi! If your purview includes investor relations, I invite you to consider applying to join Year 2 of T2B’s IR Roundtable. Apply here by midnight for one of three open spots on this roundtable. What is the IR Roundtable?Chaired by Deborah Elson, who heads up Corporate Communications and IR at Tonix Pharmaceuticals, this group brings biopharma communicators together to advance how IR and corporate communications work together to shape positioning and credibility. In Year 2, the group will continue to build on discussions many of us are actively navigating:
The roundtable will continue developing quarterly programming and practical resources for the T2B community, creating space for candid discussion and shared learning across IR-focused roles. What’s the time commitment?Members contribute ~3–5 hours per month, participate in working sessions, and co-create programming for the broader T2B community. Who should apply?We’re looking for T2B Pro members with experience in biopharma IR — in-house, agency, or consulting — who want to contribute actively and help shape how our industry approaches IR. Looking forward to seeing who will help lead the next year of IR programming for our growing T2B communicator community! Lynnea |
T2B Monthly
Hi! Burnout is often discussed as an issue for individuals to manage. But during our April Comm Convo, Beyond Self-Care to Structural Change, the discussion focused on the systems, expectations, and leadership habits that shape how sustainable our jobs are. Our speakers Arran Attridge (Attridge Communications), Nikki Little (Franco), Amanda Guisbond (Iambic), and Barbara Palmer (Broad Perspectives Consulting) discussed how burnout develops inside comms teams, why urgency drives our...
Hi! A quick reminder that T2B’s inaugural AI in Biopharma Communications Survey closes tonight. Take the survey We’re exploring how communicators are using AI in practice, what tools and governance structures are in place, where friction remains, and how the role itself may be changing. The goal is to create a benchmark our profession can actually use in conversations about policy, training, resourcing, and the future of the function. Thank you to everyone who has already taken the time to...
Hi and happy Friday! First, I want to flag that this is not one of those surveys where you can watch from afar and see what everyone else says. Yes, we have about 1,600(!) members in the T2B community, but we are calling on each of you to set aside 10 minutes to share your individual experience, hopes, fears, challenges, and expectations around AI in our profession. If we want this inaugural AI in Biopharma Communications Survey to be meaningful and instructive, we need as much data as...